From the Editor desk

Dear Readers, I am pleased to present this issue, featuring groundbreaking advancements in the clinical understanding and management of cardiovascular diseases, particularly focusing on coronary artery interventions and heart failure. Few articles demand special attention. In the first article, I had the privilege of conducting a study that introduces a simplified classification system for coronary artery angiography—the Coronary Artery Angiographic Segmental (CAAS) classification. This innovative framework aims to aid interventional cardiologists and cardiac surgeons in precisely locating anatomical sites for stent or graft implantation. The development of the Comprehensive Coronary Artery Lesion Description (CALD) code system is a significant leap forward, addressing the complexities presented by anatomical variations in coronary arteries. With this new system, we can effectively communicate the specific characteristics of lesions, enhancing pre-procedural planning and potentially improving patient outcomes. The results show that the CALD code system, with its structured 9-position format, allows for easy recollection and application in clinical settings. This issue also article which encompasses a retrospective study examining long-term survival rates and mortality predictors among 1,032 patients who underwent coronary artery bypass grafting (CABG). The results reveal impressive survival rates with 1-year, 3-year, 5-year, and 10-year outcomes at 95%, 91%, 88%, and 85%, respectively. This comprehensive analysis not only showcases the enduring efficacy of CABG but also identifies crucial factors influencing long-term survival, providing essential insights for both clinicians and patients navigating their cardiovascular health journeys. Additionally, I am excited to introduce a systematic literature review and meta-analysis of recent findings concerning coronary artery disease. The findings from this meta-analysis on dual antiplatelet therapy (DAPT) shed light on the potential of abbreviated DAPT regimens. The balance between reducing bleeding complications and maintaining ischemic protection is vital, especially for patients undergoing percutaneous coronary intervention (PCI). As we continue to explore optimal strategies for antiplatelet therapy, it is imperative for ongoing research to further investigate tailored approaches that cater to individual patient needs and enhance outcomes in the ever-evolving landscape of cardiovascular care.